Sign in

CIK 0001107421

  • Non-accelerated filer
  • Smaller reporting company

Alaunos Therapeutics, Inc.

Sign in to watch
Ticker
TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841475642
Phone
+1 346-355-4099
Business address
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
Former names
ZIOPHARM ONCOLOGY INC, EASYWEB INC
  1. 4 Grant or award COO, CLO, and Secretary acquired 65,000 shares (grant or award)
  2. 4 Grant or award Chief Executive Officer acquired 131,000 shares (grant or award)
  3. 4 Grant or award Executive Vice President R&D acquired 65,000 shares (grant or award)
  4. 4 Grant or award Vice Pres., Treasurer & CAO acquired 28,000 shares (grant or award)
  5. 4 Grant or award Director acquired 26,661 shares (grant or award)
  6. 4 Shares withheld for taxes Director gave up 9,023 shares (to pay taxes)
  7. 4 Shares withheld for taxes Director gave up 2,047 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 26,661 shares (grant or award)
  10. 4 Open-market sale COO, CLO, and Secretary sold 153,333 shares at $12.84 ($1,968,796)
  11. 4 Grant or award Director acquired 4,186 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale Executive Vice President R&D sold 50,000 shares at $10.12 ($506,000)
  14. 4 Other disposition Director disposed of 17,830,305 shares (other)
  15. 4 Open-market sale Vice Pres., Treasurer, & CAO sold 57,500 shares at an average $9.65 ($555,083)
  16. 4 Open-market sale Director sold 40,000 shares at an average $9.70 ($387,808)
  17. 4 Grant or award COO, CLO, and Secretary acquired 50,000 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 1,000,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Shares withheld for taxes EVP, CLO, and Secretary gave up 14,601 shares (to pay taxes)

Page 13 of 24 · 465 filings